Patents by Inventor Argyrios Ziogas

Argyrios Ziogas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUANTITATIVE ASSESSMENT OF INDIVIDUAL CANCER SUSCEPTIBILITY BY MEASURING DNA DAMAGE-INDUCED MRNA IN WHOLE BLOOD
    Publication number: 20090215064
    Abstract: Heparinized human whole blood from patients with invasive breast cancer, with (multiple primary) and without (single primary) a second primary cancer, and from unaffected controls was stimulated with 0.1-10 Gy of radiation and incubated at 37° C. for 2 hours. P21 and PUMA mRNA were then quantified. The results suggest that cancer susceptibility represented by the multiple primary cases was significantly related to over-reaction of p21 mRNA, and not PUMA.
    Type: Application
    Filed: February 27, 2009
    Publication date: August 27, 2009
    Applicants: HITACHI CHEMICAL CO., LTD., HITACHI CHEMICAL RESEARCH CENTER, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Masato Mitsuhashi, Hoda Anton-Culver, Argyrios Ziogas, David Peel